Improving pharmaceutical practice in diabetes care using point-of-care glycated haemoglobin testing in the community pharmacy.
Caroline Rocha SantanaMárcio Galvão Guimarães de OliveiraMarianne Silveira CamargoPablo Maciel Brasil MoreiraPriscila Ribeiro de CastroErlan Canguçu AguiarSostenes MistroPublished in: The International journal of pharmacy practice (2023)
The use of point-of-care glycated haemoglobin testing allowed community pharmacists at a Brazilian public community pharmacy to identify health system users with glycated haemoglobin alterations that corresponded to the pre-diabetes state or a new diagnosis of type 2 diabetes mellitus. This presented a good opportunity to refer these users to diabetes diagnosis and treatment services.